The federal government plans to halt its program that delivers free, at-home COVID-19 tests on Sept. 2 because of dwindling funds, according to reports from CNN and NBC News.
Category: Supply Chain
N95 masks aren’t in shortage anymore, FDA says
The COVID-19 pandemic shoved the nation’s weak supply of personal protective equipment into the limelight when hospitals scrambled to grab enough gowns, medical masks and gloves in 2020. More than two years later, N95 respirator masks exited the FDA’s …
3 strategies for a stronger supply chain: McKinsey survey
With some hospitals and health systems spending up to 40 percent of their budgets on supply, consulting company McKinsey compiled supply chain executives’ main strategies at bolstering their work and published the results Aug. 23.
Monkeypox vaccine dose-sparing causes headaches for public health officials
The latest strategy to stretch the supply of the world’s only monkeypox vaccine, Bavarian Nordic’s Jynneos, is frustrating local health officials tasked with distributing the doses, Politico reported Aug. 24.
Blood supply shortages, a defibrillator recall and 6 more supply chain updates
Here are supply chain updates that have been reported by Becker’s since Aug. 16:
5 recent medical supplier acquisitions, partnerships
Here are five recent acquisitions, deals and partnerships that have sprung up since Aug. 16:
Blood supply levels drop 50% since early summer, supplier says
Vitalant’s blood supply has dropped by nearly 50 percent since early summer, the supplier said Aug. 22, urging people to donate ahead of Labor Day weekend.
US to boost monkeypox vaccine supplies: 2 updates
An additional 1.8 million doses of the Jynneos monkeypox vaccine will be available for health departments to order starting Aug. 22, according to White House officials.
Gore-Tex maker acquires vascular devicemaker InnAVasc Medical
Devicemaker InnAVasc medical was acquired by W.L. Gore & Associates, maker of Gore-Tex, WRAL reported Aug. 18.
New York urges White House to boost monkeypox vaccine production
As monkeypox vaccine supply wanes, members of Congress from New York called on the Biden Administration Aug. 16 to invoke the Defense Protection Act, which they say would ramp up domestic production.
